2020
DOI: 10.7759/cureus.7304
|View full text |Cite
|
Sign up to set email alerts
|

Inequalities in Meningioma Survival: Results from the National Cancer Database

Abstract: Background Meningiomas are the second most common primary tumors of the central nervous system. However, there is a paucity of literature examining how healthcare, demographic, and socioeconomic factors impact patient outcomes. Methods We conducted a retrospective study of 65,812 patients from the National Cancer Database (NCDB; 2004-2012) who received treatment for their meningioma. Univariate and multivariate analyses were performed with the overall five-year survival as the primary outcome, and the followin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 10 publications
1
4
0
Order By: Relevance
“…19 World while, WHO grade III meningiomas show extremely aggressive behavior and high rates of recurrence. 20 In our study, in accordance to the histological type, the microcystic meningiomas (WHO I) had a surveillance rate of 60 months (lowest) in contrast with transitional (WHO I) with 122 months (highest). For the non-graphed variants, not enough censored data were obtained, so no data was obtained from them.…”
Section: Discussionsupporting
confidence: 57%
“…19 World while, WHO grade III meningiomas show extremely aggressive behavior and high rates of recurrence. 20 In our study, in accordance to the histological type, the microcystic meningiomas (WHO I) had a surveillance rate of 60 months (lowest) in contrast with transitional (WHO I) with 122 months (highest). For the non-graphed variants, not enough censored data were obtained, so no data was obtained from them.…”
Section: Discussionsupporting
confidence: 57%
“…The heterogeneity of this population can likely account for some of the con icting results thus far in the literature demonstrating either no difference or improved OS for Hispanic patients with meningiomas. 7,[14][15][16] We subclassi ed Hispanic ethnicity into Hispanic White and Hispanic Black to account for this admixture and its potential in uence on outcome. Hispanic White populations have signi cantly improved OS compared to White populations.…”
Section: Discussionmentioning
confidence: 99%
“…2,5,6 However, Hispanic patients have similar or improved OS compared to White patients. 7 Given that the Hispanic population has been noted to have similar SES compared to Blacks, it suggests other factors, perhaps related to differences in tumor biology amongst races and ethnicities, may contribute to the disparities observed in OS after meningioma resection.…”
Section: Introductionmentioning
confidence: 99%
“…The presence of inequalities in both disease presentation and treatment outcomes significantly impacts the well-being and survival of patients. In this context, studies have examined healthcare, demographic, and socioeconomic factors that contribute to diverse patient outcomes and HRQoL [51].…”
Section: Inequality In Hrqol Of Patients With Meningiomamentioning
confidence: 99%